Literature DB >> 35430783

KASL clinical practice guidelines for management of chronic hepatitis B.

.   

Abstract

Entities:  

Keywords:  Chronic hepatitis B; Disease management; KASL guidelines; Therapeutics; Treatment

Mesh：

Substances：

Year:  2022        PMID： 35430783      PMCID： PMC9013624          DOI： 10.3350/cmh.2022.0084

Source DB:  PubMed          Journal:  Clin Mol Hepatol        ISSN： 2287-2728


× No keyword cloud information.
  472 in total

1.  Meta-analysis: antiviral treatment for hepatitis D.

Authors:  C Triantos; M Kalafateli; V Nikolopoulou; A Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2012-01-24       Impact factor: 8.171

Review 2.  Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Authors:  Winnie Yeo; Philip J Johnson
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  Discontinuation of oral antivirals in chronic hepatitis B: A systematic review.

Authors:  George Papatheodoridis; Ioannis Vlachogiannakos; Evangelos Cholongitas; Karsten Wursthorn; Christos Thomadakis; Giota Touloumi; Jörg Petersen
Journal:  Hepatology       Date:  2016-03-04       Impact factor: 17.425

4.  Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma.

Authors:  Wei Ping Liu; Xiao Pei Wang; Wen Zheng; Ling Yan Ping; Chen Zhang; Gui Qiang Wang; Yu Qin Song; Jun Zhu
Journal:  Leuk Lymphoma       Date:  2016-01-04

5.  Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Authors:  Winnie Yeo; Tung C Chan; Nancy W Y Leung; Wai Y Lam; Frankie K F Mo; Miu Ting Chu; Henry L Y Chan; Edwin P Hui; Kenny I K Lei; Tony S K Mok; Paul K S Chan
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  The natural history of asymptomatic hepatitis B surface antigen carriers.

Authors:  R de Franchis; G Meucci; M Vecchi; M Tatarella; M Colombo; E Del Ninno; M G Rumi; M F Donato; G Ronchi
Journal:  Ann Intern Med       Date:  1993-02-01       Impact factor: 25.391

7.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

8.  Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.

Authors:  Wan-Ting Yang; Li-Wei Wu; Tai-Chung Tseng; Chi-Ling Chen; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Chun-Jen Liu; Jia-Horng Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Shijian Liu; Hongwei Zhang; Chunying Gu; Jianhua Yin; Yongchao He; Jiaxin Xie; Guangwen Cao
Journal:  J Natl Cancer Inst       Date:  2009-07-02       Impact factor: 13.506

Review 10.  Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus.

Authors:  Sun Woong Kim; Jun Sik Yoon; Minjong Lee; Yuri Cho
Journal:  Clin Mol Hepatol       Date:  2021-07-20
View more
  1 in total

1.  Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.

Authors:  Myung Ji Goh; Wonseok Kang; Woo Kyoung Jeong; Dong Hyun Sinn; Geum-Youn Gwak; Yong-Han Paik; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.